• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

ESC/ERS 4 分层风险分层模型在肺动脉高压伴变量缺失时的表现。

Performance of the ESC/ERS 4-strata risk stratification model for pulmonary arterial hypertension with missing variables.

机构信息

GWT-TUD GmbH, Innovation Center Real-World Evidence, Dresden, Germany.

Institute for Clinical Pharmacology, Medical Faculty, Technical University, Dresden, Germany.

出版信息

Eur Respir J. 2023 Nov 29;62(5). doi: 10.1183/13993003.01023-2023. Print 2023 Nov.

DOI:10.1183/13993003.01023-2023
PMID:37802633
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10695769/
Abstract

https://bit.ly/46mz83d

摘要

https://bit.ly/46mz83d

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25df/10695769/ba65fb40b7a6/ERJ-01023-2023.01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25df/10695769/ba65fb40b7a6/ERJ-01023-2023.01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25df/10695769/ba65fb40b7a6/ERJ-01023-2023.01.jpg

相似文献

1
Performance of the ESC/ERS 4-strata risk stratification model for pulmonary arterial hypertension with missing variables.ESC/ERS 4 分层风险分层模型在肺动脉高压伴变量缺失时的表现。
Eur Respir J. 2023 Nov 29;62(5). doi: 10.1183/13993003.01023-2023. Print 2023 Nov.
2
[Risk stratification methods and their significance in pulmonary arterial hypertension].[肺动脉高压的风险分层方法及其意义]
Ter Arkh. 2019 Sep 15;91(9):150-157. doi: 10.26442/00403660.2019.09.000192.
3
[Advances in pulmonary hypertension diagnosis and risk stratification].[肺动脉高压诊断与风险分层的进展]
Rev Med Liege. 2023 Feb;78(2):99-106.
4
Risk stratification, prognosis, and survival in a pulmonary arterial hypertension cohort in Latin America. A multicenter study.在拉丁美洲的肺动脉高压队列中进行风险分层、预后和生存分析。一项多中心研究。
Respir Med Res. 2023 Jun;83:100945. doi: 10.1016/j.resmer.2022.100945. Epub 2022 Dec 21.
5
[Risk stratification in pulmonary arterial hypertension - implementation of an internet-based risk calculator to guide treatment].肺动脉高压的风险分层——基于互联网的风险计算器在指导治疗中的应用
Lakartidningen. 2023 Oct 23;120:23075.
6
Evaluation of the European Society of Cardiology/European Respiratory Society derived three- and four-strata risk stratification models in pulmonary arterial hypertension: introducing an internet-based risk stratification calculator.欧洲心脏病学会/欧洲呼吸学会推导的肺动脉高压三阶层和四阶层风险分层模型评估：引入基于互联网的风险分层计算器
Eur Heart J Open. 2023 Feb 21;3(2):oead012. doi: 10.1093/ehjopen/oead012. eCollection 2023 Mar.
7
Risk stratification in patients with pulmonary arterial hypertension at the time of listing for lung transplantation.肺动脉高压患者肺移植时的风险分层。
J Heart Lung Transplant. 2022 Sep;41(9):1285-1293. doi: 10.1016/j.healun.2022.06.001. Epub 2022 Jun 6.
8
Prognostic Stratification and Treatment for Pulmonary Arterial Hypertension. Gaps and Promising Remedies.肺动脉高压的预后分层与治疗。差距与有望的补救措施。
Arch Bronconeumol. 2023 Oct;59(10):617-618. doi: 10.1016/j.arbres.2023.04.003. Epub 2023 Apr 20.
9
The added value of right ventricular function normalized for afterload to improve risk stratification of patients with pulmonary arterial hypertension.右心室功能校正后负荷的附加值可改善肺动脉高压患者的风险分层。
PLoS One. 2022 May 19;17(5):e0265059. doi: 10.1371/journal.pone.0265059. eCollection 2022.
10
Simplified risk stratification for pulmonary arterial hypertension associated with connective tissue disease.结缔组织病相关肺动脉高压的简化风险分层。
Clin Rheumatol. 2019 Dec;38(12):3619-3626. doi: 10.1007/s10067-019-04690-3. Epub 2019 Aug 5.

引用本文的文献

1
Performance of Risk-Stratification Scores for Patients With Pulmonary Arterial Hypertension in a Multi-Ethnic Asian Population.多民族亚洲人群中肺动脉高压患者风险分层评分的表现
Pulm Circ. 2024 Dec 29;15(1):e70032. doi: 10.1002/pul2.70032. eCollection 2025 Jan.
2
Risk stratification and treatment goals in pulmonary arterial hypertension.肺动脉高压的风险分层和治疗目标。
Eur Respir J. 2024 Oct 31;64(4). doi: 10.1183/13993003.01323-2024. Print 2024 Oct.
3
Prognostic role of haemodynamics at follow-up in patients with pulmonary arterial hypertension: a challenge to current European Society of Cardiology/European Respiratory Society risk tools.

本文引用的文献

1
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension.2022年欧洲心脏病学会/欧洲呼吸学会肺动脉高压诊断和治疗指南。
Eur Respir J. 2023 Jan 6;61(1). doi: 10.1183/13993003.00879-2022. Print 2023 Jan.
2
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension.2022年欧洲心脏病学会/欧洲呼吸学会肺动脉高压诊断和治疗指南。
Eur Heart J. 2022 Oct 11;43(38):3618-3731. doi: 10.1093/eurheartj/ehac237.
3
External validation of a refined four-stratum risk assessment score from the French pulmonary hypertension registry.
肺动脉高压患者随访时血流动力学的预后作用：对当前欧洲心脏病学会/欧洲呼吸学会风险评估工具的挑战
ERJ Open Res. 2024 Aug 5;10(4). doi: 10.1183/23120541.00225-2024. eCollection 2024 Jul.
法国肺动脉高压注册研究中一种改良的四分层风险评估评分的外部验证。
Eur Respir J. 2022 Jun 30;59(6). doi: 10.1183/13993003.02419-2021. Print 2022 Jun.
4
COMPERA 2.0: a refined four-stratum risk assessment model for pulmonary arterial hypertension.COMPERA 2.0：一种改良的肺动脉高压四层风险评估模型。
Eur Respir J. 2022 Jul 7;60(1). doi: 10.1183/13993003.02311-2021. Print 2022 Jul.
5
Development and Validation of an Abridged Version of the REVEAL 2.0 Risk Score Calculator, REVEAL Lite 2, for Use in Patients With Pulmonary Arterial Hypertension.REVEAL 2.0 风险评分计算器简表的制定与验证：REVEAL Lite 2，用于肺动脉高压患者
Chest. 2021 Jan;159(1):337-346. doi: 10.1016/j.chest.2020.08.2069. Epub 2020 Sep 1.
6
Use and misuse of the receiver operating characteristic curve in risk prediction.风险预测中受试者工作特征曲线的应用与误用
Circulation. 2007 Feb 20;115(7):928-35. doi: 10.1161/CIRCULATIONAHA.106.672402.